Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B

Abstract Background Current treatment options for chronic hepatitis B (CHB) are pegylated interferon alpha and nucleoside analogues (NAs). NAs have relatively fewer side effects than interferon alpha, and generally well tolerated. Previously 12.9% of patients on telbivudine treatment were reported t...

Full description

Bibliographic Details
Main Authors: Yue Ying, Yue-Kai Hu, Jia-Lin Jin, Ji-Ming Zhang, Wen-Hong Zhang, Yu-Xian Huang
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Gastroenterology
Subjects:
Lactic acidosis
Rhabdomyolysis
Mitochondrial toxicity
Myopathy
Telbivudine
Tenofovir
Online Access:http://link.springer.com/article/10.1186/s12876-018-0773-3

Internet

http://link.springer.com/article/10.1186/s12876-018-0773-3

Similar Items